JPMorgan Starts bluebird bio (BLUE) at Overweight, 'Set to Ascend on Zynteglo Launch & SCD Expansion'
Tweet Send to a Friend
(Updated - April 28, 2023 6:05 AM EDT)
JPMorgan analyst Eric Joseph initiates coverage on bluebird bio (NASDAQ: BLUE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph initiates coverage on bluebird bio (NASDAQ: BLUE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
